Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1633 of 5804
-
New hope for HIV nerve pain: Drug-Free relief on the horizon?
Symptom relief CompletedDistal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with HIV. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely in…
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Immunotherapy-Chemo combo targets tough neuroendocrine cancers
Disease control OngoingThis phase Ib trial studies how well pembrolizumab works with combination chemotherapy in treating participants with small cell/neuroendocrine cancers of the urothelium or prostate that has spread to nearby tissue or lymph nodes or that has spread to other places in the body. Mon…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a simple leg cuff cut stroke risk? new study tests EECP therapy
Disease control CompletedIntracranial stenosis is prevalent among Asians and constitute a common cause of cerebral ischemia. While the best medical therapy carries stroke recurrence rates in access of 10% per year, intracranial stenting was associated with unacceptable peri-procedural ischemic events. Ce…
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New cocktail of drugs and radiation aims to boost stomach cancer treatment before surgery
Disease control OngoingThis pilot phase I/II trial studies the side effects and how well nivolumab and ipilimumab in combination with chemotherapy and radiation therapy work in treating patients with gastric cancer that can be removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolu…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy boosts standard treatment for aggressive cervical cancer
Disease control CompletedThis phase I trial studies how well atezolizumab before and/or with standard of care chemoradiotherapy works in immune system activation in patients with stage IB2, II, IIIB, or IVA cervical cancer that has spread to the lymph nodes. Immunotherapy with monoclonal antibodies, such…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New radiation device aims to cut breast cancer treatment time
Symptom relief Recruiting nowThis study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New hope for hearing loss? drug targets inner ear inflammation
Disease control Recruiting nowA Phase II randomized, placebo controlled study design of anakinra (Kineret) in corticosteroid-resistant or intolerant Meniere's disease (CR-MD)and corticosteroid-resistant or intolerant autoimmune inner ear disease (CR-AIED) patients. Patients will be randomized by a 2:1 allocat…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a vaccine made from your own cells help control HIV?
Disease control CompletedThis study will be done in people living with HIV to see if an investigational vaccine made from a person's own white blood cells is safe and tolerated. This study will also look at the body's immune response to the vaccine and evaluate four different methods of making the vaccin…
Phase: PHASE1 • Sponsor: Sharon Riddler • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a new PET scan help match pancreatic cancer patients to the right therapy?
Diagnosis CompletedCurrently there is no clinical biomarker that can be used to select patients for CCR2-targeted therapy and to monitor response to such therapy. Considering the toxicity and the rate of response to CCR2-targeted therapy, it is crucial to be able to identify patients who may not re…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Skin clues could unmask rare nerve disease in kids
Knowledge-focused Recruiting now.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000. the clinical presentation is based on the appearance of tumors in the central and peripheral nerv…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Weight loss before IVF boosts baby chances for overweight women
Disease control CompletedThe aim of this study is to determine whether weight loss prior to in vitro fertilization (IVF) improves live birth outcomes in overweight and obese infertile women. The study prospectively analyzed 158 overweight and obese (BMI ≥ 24 kg/m2) infertile women, age between 20 and 36 …
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
Engineered immune cells take on brain cancer in early trial
Disease control CompletedIn this study, is researching the safety of tisagenlecleucel in participants with primary central nervous system lymphoma. . -The name of the study intervention is tisagenlecleucel.
Phase: PHASE1 • Sponsor: Matthew J. Frigault, M.D. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Dose debate: which rituximab regimen works best for rare blistering disease?
Disease control CompletedInvestigating the clinical efficacy of different doses of rituximab in patients with pemphigus
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can magnetic pulses ease alcohol and brain injury struggles in veterans?
Disease control ENROLLING_BY_INVITATIONThe objectives of this VA Merit application are to identify a neural target unique to Veterans with co-occurring alcohol use disorder and mild traumatic brain injury (AUD+mTBI) and to test the efficacy of this target as a stimulation site for repetitive transcranial magnetic stim…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a simple injection after a broken ankle prevent arthritis?
Disease control Recruiting nowHigh energy intra-articular fractures of the distal tibia, or Pilon fracture, is a devastating injury with multiple short and long term complications. The incidence of these injuries is increasing as survival rates after motor vehicle collisions increase. The current standard of …
Phase: PHASE4 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Experimental drug shows promise for Tough-to-Treat lymphoma
Disease control OngoingThe purpose of this study is to test any good and bad effects of the study drug, CPI-613.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental combo therapy targets hard-to-treat sarcoma
Disease control CompletedATLAS-IT-04 is a two part, single arm study designed to determine the safety and effectiveness of LTX-315 to induce T-cell infiltration prior to TIL expansion in patients with soft tissue sarcoma. Following intratumoural injection of LTX-315 to a selected lesion, the lesion will …
Phase: PHASE2 • Sponsor: Lytix Biopharma AS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New dengue vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the neutralizing antibody response against each dengue serotype post-vaccination.
Phase: PHASE2 • Sponsor: Takeda • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 14:42 UTC
-
MS drug ofatumumab tested for Long-Term safety in nearly 1,900 patients
Disease control OngoingThe purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the e…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Custom vaccine shows promise in halting rare blood cancer
⭐️ VACCINE ⭐️ CompletedThis early phase I trial studies the side effects of personalized vaccine in treating patients with smoldering multiple myeloma. Vaccines made from a person's blood and bone marrow may help the body build an effective immune response to kill cancer cells.
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:05 UTC